EarningsQ2 2026 Earnings Report
MX:MET Q2 2026 EPS Results
Actual EPS$44.13
Consensus EPS$41.68
Beat/MissBeat by +$2.45
One Year Ago EPS$36.69
MX:MET Q2 2026 Revenue Results
Actual Revenue$350.71B
Expected Revenue$357.15B
Beat/MissMissed by -$6.43B
YoY Revenue Growth+11.37%
Earnings Announcement Details
QuarterQ2 2026
Date08/05/2026
TimeAfter Close
Conference CallWednesday, August 5, 2026
MX:MET Upcoming Earnings
Metlife's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:MET Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed strong, broad-based operational performance and capital returns: adjusted earnings and EPS grew meaningfully, ROE reached the top of the target range, multiple regions delivered double-digit growth (notably Group, Asia and Latin America), AUM grew to $748 billion, and the company announced a new $3 billion buyback while maintaining a healthy holding-company cash buffer. Offsetting risks include below-guidance total spreads driven by weak private equity returns and lower-than-run-rate variable investment income, a lighter and lumpy PRT market in H1, some normalization expected in favorable Group mortality experience, and a short-term earnings impact from mark-to-market items and the PineBridge expense footprint. Overall, positive operational momentum and capital flexibility outweigh the near-term investment and market headwinds.Company Guidance
Strong Adjusted Earnings and EPS Growth
Adjusted earnings of approximately $1.6 billion ($2.43 per share); adjusted earnings rose 15% year-over-year and adjusted EPS increased 20% year-over-year.
Return on Equity at Target
Adjusted return on equity was 17%, at the top end of the company's 15% to 17% annual target range for the second quarter.
Broad-Based Sales and Revenue Growth
Adjusted premiums, fees and other revenues (excluding pension risk transfers) increased 5% year-over-year and total sales rose 7%; sales growth was broad-based across regions.
Segment-Level Outperformance — Group and Asia
Group Benefits adjusted earnings were $503 million, up 25% year-over-year with Group Life mortality ratio at 79%; Asia adjusted earnings were $420 million, up 21% reported and 25% on a constant currency basis, with sales up 17% on a constant currency basis.
Record and Strong Regional Results — Latin America and EMEA
Latin America posted a quarterly record with adjusted earnings of $268 million, up 15% reported (4% constant currency) and sales up 9% cc; EMEA adjusted earnings were $108 million, up 8% (11% cc) with sales up 15% cc.
MetLife Investment Management Growth and Scale
MIM adjusted earnings increased 6% to $57 million; total assets under management reached approximately $748 billion, up $12 billion sequentially including a $7 billion increase in institutional AUM.
Capital Return and Strong Liquidity Position
Repurchased about $700 million of common shares in the quarter and returned over $2.4 billion to shareholders year-to-date through July; announced a new $3 billion share repurchase authorization; holding company cash and liquid assets totaled $3.4 billion within the $3–$4 billion target.
Disciplined Expense Management and Productivity
Direct expense ratio was 12.1% in Q2 and management expects to meet or beat the 2026 target despite a ~50 basis point headwind from the PineBridge acquisition; company cites AI-driven productivity gains as a durable tailwind.
MX:MET Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed